Conventional antipsychotics reduce rehospitalisation in schizophrenia

By  

Inpharma, Vol. 1, Iss. 1350, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Relapse and Rehospitalisation Rates in Patients with Schizophrenia: Effects of Second Generation Antipsychotics

By Csernansky J.G.   Schuchart E.K.  

CNS Drugs, Vol. 16, Iss. 7, 2002-01 ,pp. : 473-484

Adis International

Access to resources Recommend Favorite

Safety of olanzapine versus conventional antipsychotics in the treatment of patients with acute schizophrenia. A naturalistic study

By Alvarez E.   Bobes J.   Gomez J.-C.   Sacristan J.A.   Canas F.   Carrasco J.L.   Gascon J.   Gibert J.   Gutierrez M.   for the EUROPA Study Group  

European Neuropsychopharmacology, Vol. 13, Iss. 1, 2003-01 ,pp. : 39-48

Elsevier

Access to resources Recommend Favorite

Risperidone versus Conventional Antipsychotics for Schizophrenia and Schizoaffective Disorder: Symptoms, Quality of Life and Resource Use under Customary Clinical Care

By Mahmoud R.A.   Engelhart L.M.   Janagap C.C.   Oster G.   Ollendorf D.  

Clinical Drug Investigation, Vol. 24, Iss. 5, 2004-01 ,pp. : 275-286

Adis International

Access to resources Recommend Favorite

Antipsychotics for schizophrenia in children and adolescents

By  

Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite